Experimental design for the optimization of lipid nanoparticles

Journal of Pharmaceutical Sciences

Volumn 98, Issue 5, 2009, Pages 1813-1819

  Zhang, J ^a,b   Fan, Y ^c   Smith, E ^b  

^a University of Southern Nevada   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Experimental design; Particle size; Solid lipid nanoparticles; Solvent diffusion; Zeta potential

Indexed keywords

BENZALKONIUM CHLORIDE; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYSORBATE 80; SOLID LIPID NANOPARTICLE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; MICROEMULSION; PARTICLE SIZE; TEMPERATURE MEASUREMENT;

EID: 65949113152     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21549     Document Type: Article

References (14)

1. Muller RH, Mader K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art. Eur J Pharm Sci 50:161-177.
2. Almeida AJ, Runge S, Muller RH. 2000. Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters. Eur J PharmSci 50:161-177.
3. Gasco MR. 1993. Method for producing solid lipid microspheres having a narrow size distribution, US Patent No. 5250236.
4. Siekmann B, Westesen K. 1996. Investigation on solid lipid nanoparticles prepared by precipitation in o/w emulsion. Eur J Pharm Biopharm 43:104-109.
5. Hu FQ, Yuan H, Zhang HH, Fang M. 2002. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 239:21-128.
6. Hu FQ, Jiang SP, Du YZ. 2005. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 45:167-173.
7. Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles - Evaluation of the method and process parameters. Eur J Pharm Sci 55:125-131. (Pubitemid 36120504)
8. Box GEP, Hunter WG, Hunter JS, Hunter WG. 1978. Statistics for experimenters: An introduction to design, data analysis, and model building. New York: Wiley.
9. Julienne MC, Alonso MJ, Gomez Amoza JL, Benoit JP. 1992. Preparation of poly(D,L-lactide/glycolide) nanoparticles of controlled particle size distribution: Application of experimental designs. Drug Dev Ind Pharm 18:1063-1077.
10. Molpeceres J, Guzmam M, Aberturas MR, Chacon M, Berges L. 1996. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. J Pharm Sci 85:206-213.
11. Lewis GA, Mathieu D, Phan-Tan-Luu R. 1999. Pharmaceutical experimental design. New York: Marcel Dekker, Inc. pp 186-191.
12. Mehnert W, Mader K. 2001. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 47:165-196.
13. Byrappa K, Ohachi T. 2003. Crystal growth technology. Berlin, Germany: Springer. pp 325.
14. Freitas C, Muller RH. 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions. Int J Pharm 168:221-229.